HeartSheet's Challenges And Withdrawal Hurt Japan's Cell Therapy Hopes

 
• By Lisa Takagi

Despite it’s initial promise, a novel autologous cell transplant therapy for severe heart failure has faced multiple challenges gaining full approval in Japan, potentially offering lessons for other regenerative medicine developers.

HeartSheet was heart to provide a new treatment option for severe heart failure to avoid heart transplant.
HeartSheet is a new option for severe heart failure in Japan, but challenges abound. • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies